ISRCTN16683564: Using L-NAC to reverse breathing problems caused by opioid medication
- Overall study status
- Ongoing
- Recruitment status
- Not yet recruiting
L-NAC (N-acetyl-N-cysteine or fluimicil) for reversal of opioid-induced respiratory depression
The International Traditional Medicine Clinical Trial Registry has joined the WHO Registry Network. It registers studies of traditional medicine from any country, including Chinese medicine and acupuncture, has editors specialising in traditional medicine and accepts submissions in either English or Chinese.
The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies (whether proposed, ongoing or completed), providing content validation and curation and the unique identification number necessary for publication. All study records in the database are freely accessible and searchable.
ISRCTN supports transparency in clinical research, helps reduce selective reporting of results and ensures an unbiased and complete evidence base.
ISRCTN accepts all studies involving human subjects or populations with outcome measures assessing effects on human health and well-being, including studies in healthcare, social care, education, workplace safety and economic development. The registry welcomes submissions in English from any location. Studies should ideally be registered prospectively (before recruitment starts). ISRCTN also accepts studies registered retrospectively once they are underway or after completion.
L-NAC (N-acetyl-N-cysteine or fluimicil) for reversal of opioid-induced respiratory depression
Assessment of the interaction between myocardial structure and hemodynamics in the ascending aorta in cardiovascular diseases with alteration of the outflow tract and the aortic valve using ultra-high-field magnetic resonance imaging
International living donor liver transplant registry